Au Royaume-Uni, les demandes de médicaments injectables pour la perte de poids Wegovy, Mounjaro et Ozempic explosent. Des ...

Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...

Men receiving tirzepatide showed greater reductions in body weight and waist circumference and improvements in erectile ...

Tirzepatide use vs placebo was associated with slower decline in eGFR among patients with prediabetes and obesity or overweight.

Meilleur accès aux traitements ou gains de vente pour les fabricants ? L’initiation des médicaments anti-obésité, dits agonistes du GLP-1 (Wegovy/sémaglutide, Mounjaro/tirzépatide, Saxenda/liraglutide ...

Researchers analyzed nearly 60,000 public Facebook posts to identify real-world adverse events linked to GLP-1 receptor ...

Researchers found that tirzepatide, a medication primarily used for treating type 2 diabetes and weight loss, reduced body ...

The popular weight-loss and diabetes drugs could play a significant role not only in disease prevention, but possibly in ...

Tirzepatide improves outcomes in patients with obesity-related HFpEF regardless of the severity of their baseline BMI or fat ...

The Danish firm blamed the move to slash its guidance on intense competition from rivals and copycat drugs in the US.

Tirzepatide may confer larger increases in testosterone levels among men with metabolic hypogonadism than testosterone ...

Un espoir thérapeutique pour des millions de personnes. Les États-Unis ont donné mercredi 8 novembre leur feu vert à un nouveau traitement très attendu contre l’obésité, le Zepbound. La ...